A clinical trial to study the effect of a chemical on dental pain when added to regular anesthesia injection in children.
- Conditions
- Health Condition 1: K040- Pulpitis
- Registration Number
- CTRI/2023/01/049239
- Lead Sponsor
- Dr Raghuram Chilukuri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients in 6 years to 9 years of age group with ability to understand pain record scales With positive or definitely positive behavior as per Frankel behavior rating scale With parental consent With primary mandibular second molars showing symptoms of irreversible pulpitis having lingering response to cold test With moderate to severe pain in Heft Parker Visual Analogue scale after cold test With no radiographic alterations of periodontal ligament space and fully formed roots
Patients having history of allergies to magnesium sulphate or local anesthesia or other medications Uncooperative patients Patients having history of significant medical conditions Patients taking beta blockers and opioids preoperatively Patients with primary mandibular second molars with signs of irreversible pulpitis with no pain responding normally to cold test Presence of periodontal ligament space enlargement and presence of periapical radiolucency in radiographic examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is to evaluate and compare the effect of pulpal anesthesia achieved when inferior alveolar nerve block is given with lignocaine hydrochloride containing magnesium sulphate to that of inferior alveolar nerve block containing lignocaine hydrochloride without magnesium sulphate in treatment of irreversible pulpitis in primary mandibular second molars. Pulpal Pain levels of the patient while performing pulpectomy procedure will be assessed after intervention. <br/ ><br>Timepoint: Pain levels will be assessed for a span of 1 hour while doing pulpectomy after administering nerve block.
- Secondary Outcome Measures
Name Time Method Secondary outcome is the onset duration and adverse affects on adding magnesium sulphate to lignocaine hydrochloride local anesthesia in inferior alveolar nerve blockTimepoint: 24 hours